Roadblocks for integration of novel biomarker concepts into clinical routine: the peptoid approach

by Vanderstichele, Hugo, Kodadek, Thomas
Published 2014

Potential sources of interference on Abeta immunoassays in biological samples

by Vanderstichele, Hugo, Stoops, Erik, Vanmechelen, Eugeen, Jeromin, Andreas
Published 2012

No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF

by Cicognola, Claudia, Chiasserini, Davide, Eusebi, Paolo, Andreasson, Ulf, Vanderstichele, Hugo, Zetterberg, Henrik, Parnetti, Lucilla, Blennow, Kaj
Published 2016

The discrepancy between presenilin subcellular localization and γ-secretase processing of amyloid precursor protein

by Cupers, Philippe, Bentahir, Mustapha, Craessaerts, Katleen, Orlans, Isabelle, Vanderstichele, Hugo, Saftig, Paul, De Strooper, Bart, Annaert, Wim
Published 2001

Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes

by Vanderstichele, Hugo Marcel Johan, Janelidze, Shorena, Demeyer, Leentje, Coart, Els, Stoops, Erik, Herbst, Victor, Mauroo, Kimberley, Brix, Britta, Hansson, Oskar
Published 2016

Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer’s Disease

by Niemantsverdriet, Ellis, Goossens, Joery, Struyfs, Hanne, Martin, Jean-Jacques, Goeman, Johan, De Deyn, Peter Paul, Vanderstichele, Hugo, Engelborghs, Sebastiaan
Published 2016

A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid

by Kruse, Niels, Schlossmacher, Michael G., Schulz-Schaeffer, Walter J., Vanmechelen, Eugeen, Vanderstichele, Hugo, El-Agnaf, Omar M., Mollenhauer, Brit
Published 2016

Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease

by Adamczuk, Katarzyna, Schaeverbeke, Jolien, Vanderstichele, Hugo M. J., Lilja, Johan, Nelissen, Natalie, Van Laere, Koen, Dupont, Patrick, Hilven, Kelly, Poesen, Koen, Vandenberghe, Rik
Published 2015

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease

by Janelidze, Shorena, Zetterberg, Henrik, Mattsson, Niklas, Palmqvist, Sebastian, Vanderstichele, Hugo, Lindberg, Olof, van Westen, Danielle, Stomrud, Erik, Minthon, Lennart, Blennow, Kaj, Hansson, Oskar
Published 2016

Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs

by Lerche, Stefanie, Brockmann, Kathrin, Pilotto, Andrea, Wurster, Isabel, Sünkel, Ulrike, Hobert, Markus A., von Thaler, Anna-Katharina, Schulte, Claudia, Stoops, Erik, Vanderstichele, Hugo, Herbst, Victor, Brix, Britta, Eschweiler, Gerhard W., Metzger, Florian G., Maetzler, Walter, Berg, Daniela
Published 2016

Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team

by Arnerić, Stephen P., Batrla-Utermann, Richard, Beckett, Laurel, Bittner, Tobias, Blennow, Kaj, Carter, Leslie, Dean, Robert, Engelborghs, Sebastiaan, Genius, Just, Gordon, Mark Forrest, Hitchcock, Janice, Kaplow, June, Luthman, Johan, Meibach, Richard, Raunig, David, Romero, Klaus, Samtani, Mahesh N., Savage, Mary, Shaw, Leslie, Stephenson, Diane, Umek, Robert M., Vanderstichele, Hugo, Willis, Brian, Yule, Susan
Published 2016